What Happens when Your Cryo Storage Can’t Keep Up? Cryogenic storage rarely makes it onto the list of things that sink a cell and gene therapy program. And that’s exactly the problem. By the time cryogenic storage becomes visibly unmanageable, with freezers multiplying down the hallway, operators spending hours tracking down a single sample, or […]
View Blog
Sample inventory management is a continuous process that supports the integrity of your data and research. Yet with samples and critical reagents added over time, sprawling inventories can strain valuable time, energy, and resources. An objective inventory review, conducted by better storage management experts, can help to optimize your sample and material storage and sustain […]
View Blog
Proper storage of biological assets is vital to keep your research moving forward. Yet, while you focus on research activities, it’s all too common for sample and critical reagent inventories to morph into an unorganized sprawl. The most obvious impact is time spent finding your materials of interest, but there are other consequences to sample […]
View Blog
A Strategic Guide for U.S. Pharmaceutical Manufacturers As more pharmaceutical companies bring drug manufacturing stateside, a critical but often under-planned question arises: what happens to your product after it leaves the manufacturing floor? For products requiring strict temperature control and regulatory compliance, storage isn’t just about holding space. It’s about protecting product integrity, meeting regulatory […]
View Blog
Azenta Life Sciences has officially opened its state-of-the-art biorepository facility in the Greater Boston area, designed to serve the unique storage and management needs of the biotech and life sciences industries. Located strategically to support Cambridge and Boston’s vibrant community of biotech and pharmaceutical companies, the facility offers advanced sample storage and handling capabilities, helping […]
View Blog
Part 1 of our Cryo Cold Chain Management for CGT Series With a projected rate of 10-20 product approvals per year, the global cell and gene therapy (CGT) industry is rapidly evolving. The clinical pipeline delivers a promise to the patient population with unmet medical needs ranging from oncology to autoimmune diseases and rare genetic conditions. In […]
View Blog
Imagine a scenario where a prominent life sciences company safeguards 573,000 biological samples collected two decades ago during a groundbreaking study. Today, these samples rest in a tucked-away basement of a modest laboratory, nestled among numerous cryogenic freezers within a section of the building inaccessible to anyone involved in the original research. The samples intermingle […]
View Blog
The field of cell and gene therapy (CGT) is experiencing an exciting transformation, marked by the recent FDA approval for the first CRISPR-based sickle cell treatment. As the CGT landscape rapidly expands, it’s important for stakeholders to address the challenges of scalability head-on. Cryopreservation emerges as a critical yet understated element in the scalability equation, essential for […]
View Blog
The ever-expanding horizon of medical research and healthcare delivery owes a significant debt to the technological advancements that have shaped the industry. Among the many innovations, cryopreservation stands out as a pivotal technique that preserves the integrity and functionality of biological specimens over extended periods. By freezing cells, tissues, and even whole organs at sub-zero […]
View Blog
Recap of an Interview with David Lewandowski, Azenta Life Sciences, and Carol Houts, Chief Strategy Officer at Germfree, in partnership with Phacilitate The cutting-edge domain of cell and gene therapies is undergoing a remarkable transformation, with innovative technologies and groundbreaking treatments promising to revolutionize healthcare. However, as these therapies continue to advance, so do the challenges surrounding […]
View Blog